Bibliographic information
GuidelineTherapeutics and COVID-19: living guideline, August 2025
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Updated
We recommend not to use VV116, for patients with COVID-19, regardless of disease severity except in the context of a clinical trial
Recommended against
Strong
Certainty of evidence
Very low
Notes and Remarks
Practical info The GDG made a recommendation against using VV116 for treatment of patients with non-severe, severe or critical COVID-19 outside the setting of a clinical trial and therefore practical considerations are less relevant for this drug.